×

img Accessibility Controls

Technologies Banner

All Technologies

One drop nasal vaccine based on flu vaccine candidate M2SR [CoroFlu]

Implementing Organization

Bharat Biotech, Hyderabad
Principal Investigator
Vipin KV
aircorpofficial@gmail.com

Project Overview

Unique intranasal vaccine for Coronavirus ‘CoroFlu’ is under development. Bharat Biotech is manufacturing the vaccine, conduct clinical trials, and prepare to produce almost 300 million doses of vaccine for global distribution.
Funding Organization
Quick Information
Thrust Areas
COVID-19 Research
Focus Area
Development of nasal vaccine for COVID-19
Output
TRL: Technology Readiness Level
Commercialized
arrowtop
Latest Updates
Loading…